US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Paradigm Biopharmaceuticals Ltd (PK) (PBIGF) 銘柄情報

Paradigm Biopharmaceuticals Ltd (PK) (PBIGF)

0.1754

0.0097

(5.85%)

終了 6月21日 5:00AM

Paradigm Biopharmaceuticals Ltd (PK) (PBIGF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.1754

( 5.85% )

買値

0.011

売値

12,000.18

出来高

3,840

0.14285 日の範囲 0.1754

0.10086 52 週間の範囲 0.3468

時価総額

前日終値

0.1657

始値

0.14285

時刻

最終取引時間

財務取引量

US$ 641

VWAP

0.166923

平均取引量 (3 か月)

US$ 1,935,329

発行済株式数

525,456,672

配当利回り

PER

-1.72

1 株当たり利益 (EPS)

-0.1

歳入

8.45k

純利益

-36.09M

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Australia

設立

2026

Paradigm Biopharmaceuticals Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker PBIGF. The last closing price for Paradigm Biopharmaceutic... (PK) was US$0.17. Over the last year, Paradigm Biopharmaceutic... (PK) shares have traded in a share price range of US$ 0.10086 to US$ 0.3468.

Paradigm Biopharmaceutic... (PK) currently has 525,456,672 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... (PK) is US$92.17 million. Paradigm Biopharmaceutic... (PK) has a price to earnings ratio (PE ratio) of -1.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0299	20.5498281787	0.1455	0.1754	0.1374	4833	0.15969448	CS
4	0.0254	16.9333333333	0.15	0.1754	0.10086	29925	0.12344135	CS
12	-0.0046	-2.55555555556	0.18	0.2004	0.10086	29695	0.13325138	CS
26	-0.0567	-24.429125377	0.2321	0.255	0.10086	21331	0.15038197	CS
52	-0.0412	-19.0212373038	0.2166	0.3468	0.10086	20124	0.21301543	CS
156	-0.4823	-73.3313060666	0.6577	0.67	0.10086	15668	0.21911965	CS
260	-1.4146	-88.9685534591	1.59	1.892	0.10086	11467	0.28511612	CS

PBIGF - Frequently Asked Questions (FAQ)

What is the current Paradigm Biopharmaceuticals Ltd (PK) share price?

The current share price of Paradigm Biopharmaceuticals Ltd (PK) is US$ 0.1754

How many Paradigm Biopharmaceuticals Ltd (PK) shares are in issue?

Paradigm Biopharmaceuticals Ltd (PK) has 525,456,672 shares in issue

What is the market cap of Paradigm Biopharmaceuticals Ltd (PK)?

The market capitalisation of Paradigm Biopharmaceuticals Ltd (PK) is USD 92.17M

What is the 1 year trading range for Paradigm Biopharmaceuticals Ltd (PK) share price?

Paradigm Biopharmaceuticals Ltd (PK) has traded in the range of US$ 0.10086 to US$ 0.3468 during the past year

What is the PE ratio of Paradigm Biopharmaceuticals Ltd (PK)?

The price to earnings ratio of Paradigm Biopharmaceuticals Ltd (PK) is -1.72

What is the cash to sales ratio of Paradigm Biopharmaceuticals Ltd (PK)?

The cash to sales ratio of Paradigm Biopharmaceuticals Ltd (PK) is 11.19k

What is the registered address of Paradigm Biopharmaceuticals Ltd (PK)?

The registered address for Paradigm Biopharmaceuticals Ltd (PK) is 500 Collins Street, Melbourne, Victoria, 3000

What is the Paradigm Biopharmaceuticals Ltd (PK) website address?

The website address for Paradigm Biopharmaceuticals Ltd (PK) is www.paradigmbiopharma.com

Which industry sector does Paradigm Biopharmaceuticals Ltd (PK) operate in?

Paradigm Biopharmaceuticals Ltd (PK) operates in the Biotechnology & Life Sciences sector

Watts Watt

Watts Watt 2分前

What a crock. There exists no ongoing relationship between Engel and LQMT. Another fall out caused by Chung and Steipp phu kups.

misterfishman

misterfishman 6分前

Thats too bad.its such a catchy name too it roll of the tough.

Implanting

Implanting 7分前

Yes, the different timelines from past bubbles IMO can come sooner or later as they move forward. The stats show us that, but most of these bubbles come from a result of some sort of new technology or advent (like the railroads or early telegraph/telephone) that changed the world forever.

surrealistrader

surrealistrader 8分前

Nobody needs that level of stress. I’d much prefer being bored than terrorized by my holdings in retirement.

If Sidney sat on an economic mineral deposit, I think we should suppose their actions would have gone differently over these years. They would have begun working to prove their

MONTI KING

MONTI KING 15分前

I feel like it is very likely that ENZC might merge with VGLS/ bio molecular.

Henk van vleuten

Henk van vleuten 15分前

What about coming week, we ended good on friday. Are you Guys expecting a Russel run up or we have to wait for news?

beartrap12

beartrap12 24分前

Mani, approval will not be held up by construction of the C-suite. As you know, according to the last quarterly the company plans to lease a fully-operational c-suite and use those clean rooms. That means they can start sooner than if they wait to build out the Sawston C-suite.

From t

tradedays1224

tradedays1224 27分前

Only have year until his note conversion then he will do huge RS. That’s the only way he wants it to move… when he can benefit… that is why he switch to saying good things “take time”

sunspotter

sunspotter 31分前

"Excellent writing skill"

The poster used an AI Large Language Model to generate that post - such models can produce good prose, but are also prone to hallucinations.

Better to rely on common sense than ChatGPT fed with a leading and biased question.

In t

capgain

capgain 32分前

Happy Fathers Day all.

frrol

Welcome to reality. Keep your head out of the sand.

theorysuit

theorysuit 33分前

Speculation. Why would you need to be speculating? Oh yeah the company doesn't update you. Is it approved yet close to 3 years since submission....nope that is beyond ridiculous. Keep it simple stupid....KISS

flipper44

flipper44 34分前

BNOS Conference Theme “Local-Therapies for Brain Cancer” celebrates the exciting progress at the crossroads of neuro-oncology, biology, and technology, advances that are transforming treatment approaches and offering new hope for patients. — BNOS Congress July 1-3, 2026

http

exisnet

exisnet 34分前

$ERII has the potential be big with Iran becoming a 'normal' country

NASDAQ2020

NASDAQ2020 48分前

Elite's Unique IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone.

Patent Pending
NDA ?

Quote Nasrat:

”I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10

DJurg

What is the estimate for the #MW FCEL will ship this year? Anyone?

tkg

Credit again to DJknows for bringing this to our attention...this is a very intriguing company the more I look into it!

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
19 Jun 2026
4 min read

https://iqm.tech/pres

Bngo

Do you still think Elite is scam? Are you still just asking for just $0.12, or do you think Elite is worth much more than $0.12?

Elite made the list!

84% confidence

ROE: 32.9%

Debt/Equity: 0.02x

Net Marg

Lime Time

Lime Time 60分前

I will put all my paper boy money into this. Some new entity will run this like 2021 craze. Happy Father's Day

Bngo

Bngo 1時間前

Are you still just asking for just $1.50, or do you think Elite is worth much more than $1.50?
Elite made the list!

84% confidence

ROE: 32.9%

Debt/Equity: 0.02x

Net Margin: 24.4%

Rev G

PutzMueler

PutzMueler 1時間前

The more the merrier.

NioCorp’s Mgmt, is NioCorp’s Fatal Flaw

REE’s not in the plans until they had no choice.

Just my opinion.

100lbStriper

100lbStriper 1時間前

Netlist demands ban on Samsung HBM and DRAM in the US https://www.sammyfans.com/2026/06/20/netlist-demands-ban-on-samsung-hbm-and-dram-in-the-us/#google_vignette

Paradigm Biopharmaceutic... (PK)

Burley Minerals

Amundi MSCI China Tech U...

ANTAM Persero Tbk PT

Gabelli Dividend and Inc...

0.666% until 19mar40 0.6...

iShares iBonds Dec 2029 ...

iShares MSCI USA Quality...

Constellation Technologies

Greater Community Bancorp

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。